Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 84, Issue 1, 2011, Pages 253-258

  Kuo, Yung Chih ^a   Yu, Hsin Wei ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Didecyl dimethylammonium bromide; Nanoparticle; Poly(lactide co glycolide); Surface atom; Surface coverage

Indexed keywords

DIMETHYLAMMONIUM; GLYCOLIDE; LACTIDES; POLY(LACTIDE-CO-GLYCOLIDE); POSITIVELY CHARGED; STIRRING RATES; SURFACE ATOM; SURFACE COVERAGE; SURFACE COVERAGES; WEIGHT PERCENTAGES;

EMULSIFICATION; MICROEMULSIONS; NANOPARTICLES; ZETA POTENTIAL;

BROMINE COMPOUNDS;

BROMINE DERIVATIVE; DIDECYLDIMETHYLAMMONIUM BROMIDE; NANOPARTICLE; POLYGLACTIN; UNCLASSIFIED DRUG;

ADSORPTION KINETICS; ARTICLE; ATOM; CHEMICAL BINDING; CHEMICAL STRUCTURE; CONTROLLED STUDY; MATHEMATICAL MODEL; MICROEMULSION; MOLECULAR STABILITY; NANOANALYSIS; NANOFABRICATION; PARTICLE SIZE; PRIORITY JOURNAL; SHEAR STRESS; SURFACE PROPERTY; ZETA POTENTIAL;

LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MODELS, BIOLOGICAL; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; QUATERNARY AMMONIUM COMPOUNDS; SURFACE PROPERTIES;

EID: 79951672614     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.01.009     Document Type: Article

References (25)

1. Anderson J.M., Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 1997, 28:5-24.
2. Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv. Drug Deliv. Rev. 2001, 47:65-81.
3. Kuo Y.C., Chen H.H. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier. Int. J. Pharm. 2006, 327:160-169.
4. Kuo Y.C., Su F.L. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int. J. Pharm. 2007, 340:143-152.
5. Kuo Y.C., Kuo C.Y. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers. Int. J. Pharm. 2008, 351:271-281.
6. Zhang Y., Zhu S., Yin L., Qian F., Tang C., Yin C. Preparation, characterization and biocompatibility of poly(ethylene glycol)-poly(n-butyl cyanoacrylate) nanocapsules with oil core via miniemulsion polymerization. Eur. Polym. J. 2008, 44:1654-1661.
7. Kwon H.Y., Lee J.Y., Choi S.W., Jang Y., Kim J.H. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf. A 2001, 182:123-130.
8. Wischke C., Schwendeman S.P. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int. J. Pharm. 2008, 364:298-327.
9. Xu Y., Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm. 2003, 250:215-226.
10. Verger M.L., Fluiger L., Kim Y., Hoffman M., Maincent P. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur. J. Pharm. Biopharm. 1998, 46:137-143.
11. Fontana G., Licciardi M., Mansueto S., Schillaci D., Giammona G. Amoxicillin-loaded polyethylcyano-acrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 2001, 22:2857-2865.
12. Kuo Y.C. Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles. Int. J. Pharm. 2005, 290:161-172.
13. Zambaux M.F., Bonneaux F., Gref R., Maincent P., Dellacherie E., Alonso M.J., Labrude P., Vigneron C. Influence of experimental parameters on the characteristics of poly (lactic acid) nanoparticles prepared by a double emulsion method. J. Control. Release 1998, 50:31-40.
14. Bala I., Bhardwaj V., Hariharan S., Sitterberg J., Bakowsky U., Kumar Ravi M.N.V. Design of biodegradable nanoparticles: a novel approach to encapsulating poorly soluble phytochemical ellagic acid. Nanotechnology 2005, 16:2819-2822.
15. Freiberg S., Zhu X.X. Polymer microspheres for controlled drug release. Int. J. Pharm. 2004, 282:1-18.
16. Dickinson E. Hydrocolloids as emulsifiers and emulsion stabilizers. Food Hydrocolloid 2009, 23:1473-1482.
17. Kuo Y.C., Lin S.C. Effect of glutamate on the electrical properties of cationic solid lipid nanoparticles containing stearylamine and dioctadecyldimethyl ammonium bromide. J. Phys. Chem. B 2008, 112:4454-4460.
18. Kuo Y.C., Chen H.H. Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int. J. Pharm. 2009, 365:206-213.
19. Kuo Y.C., Wang C.C. Electrophoresis of human brain microvascular endothelial cells with uptake of cationic solid lipid nanoparticles: effect of surfactant composition. Colloids Surf. B 2010, 76:286-291.
20. Kuo Y.C., Chung J.F. Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Colloids Surf. B 2011, 83:299-306.
21. Gasparini G., Kosvintsev S.R., Stillwell M.T., Holdich R.G. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification. Colloids Surf. B 2008, 61:199-207.
22. Kluge J., Fusaro F., Casas N., Mazzotti M., Muhrer G. Production of PLGA micro- and nanocomposites by supercritical fluid extraction of emulsions: I. Encapsulation of lysozyme. J. Supercrit. Fluids 2009, 50:327-335.
23. Jalil R., Nixon J.R. Microencapsulation using poly(l-lactic acid) II: preparative variables affecting microcapsule properties. J. Microencapsulation 1990, 7:25-39.
24. Y.C. Kuo, P.I. Lin, C.C. Wang, Targeting nevirapine delivery across human brain microvesscular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles, Nanomedicine, in press.
25. Kuo Y.C., Chiu K.H. Inverted colloidal crystal scaffolds with laminin-derived peptides for neuronal differentiation of bone marrow stromal cells. Biomaterials 2011, 32:819-831.